Gayatri Bio Organics Share Price
7.41+0.00 (+0.00%)
-36.77% past 1 Year
Gayatri Bio Organics Ltd is one of the largest manufacturing units of starch liquid glucose sorbitol and allied products in south India with a wide distribution network across the country.The
Corporate filings & documents
Announcements
Notice of AGM for the FY 2025-26 scheduled to be held on 23.09.2026
2 days agoNotice of AGM for the FY 2025-26 scheduled to be held on 23.09.2026
2 days agoAnnual Report for the FY 2025-26 of the Company.
2 days agoAnnual Report for the FY 2025-26 of the Company.
2 days agoResignation Letter
4 weeks agoResignation Letter
4 weeks agoChange in Management
1 month agoChange in Management
1 month agoOutcome of Board Meeting held on 04.08.2026
1 month agoUnaudited Finacial Results along with Limited Review Report for the quarter ended 30.06.2026
1 month agoUnaudited Finacial Results along with Limited Review Report for the quarter ended 30.06.2026
1 month agoGayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve 1. Un-audited Financial Results along with Limited Review Report for the Quarter ended 30.06.2026.2. Any other business with the permission of the Chair.
1 month agoGayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve 1. Un-audited Financial Results along with Limited Review Report for the Quarter ended 30.06.2026.2. Any other business with the permission of the Chair.
1 month agoCertificate under Reg 74(5) of SEBI (DP) Regulations 2018
1 month agoCertificate under Reg 74(5) of SEBI (DP) Regulations 2018
1 month agoClosure of trading window for Unaudited Financial Results for the quarter ended 30.06.2026
2 months agoClosure of trading window for Unaudited Financial Results for the quarter ended 30.06.2026
2 months agoAnnual Secretarial Compliance Report for the Year ended 31.03.2026
3 months agoSubmission of Revised Audited Financial Results for the Quarter and Year Ended 31.03.2026 due to typographical error for Board Meeting held on 19.05.2026
3 months agoSubmission of Revised Audited Financial Results for the Quarter and Year Ended 31.03.2026 due to typographical error for Board Meeting held on 19.05.2026
3 months agoSubmission of Revised Audited Financial Results for the Quarter and year Ended 31.03.2026 for Board Meeting held on 19.05.2026
3 months agoSubmission of Revised Audited Financial Results for the Quarter and year Ended 31.03.2026 for Board Meeting held on 19.05.2026
3 months agoRe- Appointment of M/s. Vas & Co. Chartered Accountants as Internal Auditors of the Company for Financial Year 2026-27
3 months agoRe- Appointment of M/s. Vas & Co. Chartered Accountants as Internal Auditors of the Company for Financial Year 2026-27
3 months agoOutcome of Board Meeting held on 19.05.2026
3 months agoOutcome of Board Meeting held on 19.05.2026
3 months agoAudited Financial Results along with Audit Report for quarter and year ended 31.03.2026
3 months agoAudited Financial Results along with Audit Report for quarter and year ended 31.03.2026
3 months agoGayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve the Audited financial results of the company along with auditreport for the quarter and year ended 31.03.2026
3 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Gayatri BioOrganics Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24110TG1991PLC013512</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>FY 2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>FY 2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Huda Khan</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Achanta Prabhakar Rao</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 01/05/2026<br/><br/></div>
4 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Gayatri BioOrganics Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24110TG1991PLC013512</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>FY 2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>FY 2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Huda Khan</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Achanta Prabhakar Rao</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 01/05/2026<br/><br/></div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Gayatri BioOrganics Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24110TG1991PLC013512</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>2.07</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Huda Khan <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Achanta Prabhakar Rao <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Gayatri BioOrganics Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24110TG1991PLC013512</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>2.07</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Huda Khan <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Achanta Prabhakar Rao <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoCertificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.
4 months agoCertificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.
4 months agoIntimation of Postponement of Board Meeting which was scheduled to be held on 15.04.2026
4 months agoIntimation of Postponement of Board Meeting which was scheduled to be held on 15.04.2026
4 months agoGayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2026 inter alia to consider and approve Reduction of capital
4 months agoGayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2026 inter alia to consider and approve Reduction of capital
4 months agoClosure of trading window
5 months agoClosure of trading window
5 months agoClarification on Price Movement
5 months agoThe Exchange has sought clarification from Gayatri BioOrganics Ltd on March 13 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months agoThe Exchange has sought clarification from Gayatri BioOrganics Ltd on March 13 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months agoNewspaper Publication for the Unaudited Financial Results for the quarter and nine months ended 31.12.2025.
6 months agoOutcome of Board meeting held on 10.02.2026
6 months agoUnaudited quarterly results for quarter ended 31.12.2025
6 months agoGayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Unaudited financial results for the quarter and nine months ended 31-12-2025.
7 months agoCompliance Certificate under Reg.74(5) of SEBI (DP) Regulations 2018
7 months agoClosure of trading window for Unaudited Financial Results for the quarter ending 31.12.2025
8 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
6-3-1090, ‘ B 1 1st Floor Tsr Towers, Raj Bhavana Road Somajiguda Hyderabad Telangana PIN: 500082 Tel No: 040 66100111 / 222 Fax No: 040 66100333 Email: [email protected] / [email protected] Internet: www.gayatribioorganics.com
Registrars
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II, Gachibowli(Old Address:12-10-167, MIG- 167,Bharat Nagar Colony, Hyderabad – 500018.)Phone: +91-40-23818475/6Fax : +91-40-23868024Email: info@vccili Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57 4th & 5th Floors Jayabheri Enclave Phase - II, Gachibowli PIN: Tel No: 23818475,23868257,35164910 Fax No: NULL Email: [email protected] Internet: www.vccipl.com
Management
Kanaparthi Sreedhara Reddy, Chairman and Managing Director
Kanaparthi Sreedhara Reddy, Chairman and Managing Director
PV Narayana Rao, Non Executive Independent Director
Meenakshi Ramchand Sachdeva, Non Executive Independent Director
Srinivas Iduri, Non Executive Independent Director
Huda Khan, Company Secretary and Compliance Officer
Details
BSE 524564
NSE NULL
ISIN INE052E01015